HopeStage
Back to all studies
Active Not RecruitingNCT03995121

PET imaging with a new tracer in psychosis and cannabis use

About this titleRead the official source — NCT03995121
Observational studyAges 18–85United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 85 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2017
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
250
Sponsor
Yale University
Sponsor type
University
Study type
Observational
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 85 Years
Official registry ID
NCT03995121
Official title
Show the full official title

Synaptic Density in Psychiatric Disorders Using SV2A Receptor PET Imaging With [11C]APP311

Recruitment & locations

Not recruiting

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Does this study involve medication?

Yes. The study involves medication, including [11C]APP311.

Who can participate?

Listed age limits: 18 years to 85 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies